• ARK funds bought 62,497 Rocket Lab (RKLB) shares as RKLB agreed to acquire Iridium for about $8B; Iridium shareholders get $27 cash plus RKLB stock under a collar; deal expected to close mid‑2027.
  • Citizens keeps Market Outperform and $130 target on Rocket Lab (RKLB), citing Neutron progress, renewed demand after Farnborough, and potential ~98% upside if Neutron succeeds and missions execute.